[Skip to Navigation]
February 1980

Disabling Pansclerotic Morphea of Children

Author Affiliations

From the Department of Dermatology, Mayo Clinic and Mayo Foundation, Rochester, Minn.

Arch Dermatol. 1980;116(2):169-173. doi:10.1001/archderm.1980.01640260045011

• Fourteen children with generalized morphea involving all levels of the skin and soft tissues were examined. The term "acral pansclerotic morphea" describes the distribution and the multiple levels of sclerosis. Lymphocytic inflammation and hyaline panniculitis were observed on biopsy specimens in some cases. Laboratory data were characterized by a polyclonal elevation of γ-globulin level and by peripheral eosinophilia. Pulmonary changes in five patients and esophageal changes in one imply that acral pansclerotic morphea may be associated with mild nonporgressive visceral change. Although cyclophosphamide may retard the process, no satisfactory treatment for progressive, mutilating acral pansclerotic morphea has been found.

(Arch Dermatol 116:169-173, 1980)

Add or change institution